Neutralizing antibody to Mengo virus, induced by synthetic peptides

Area of Science:

• Virology
• Immunology
• Vaccine Development

Background:

• Mengo virus is an RNA virus causing significant disease.
• Understanding the viral capsid protein VP1's role in immunity is crucial.
• Developing effective vaccines against Mengo virus is a public health priority.

Purpose of the Study:

• To investigate the immunogenic potential of a specific peptide from Mengo virus VP1.
• To evaluate the capacity of this peptide to induce neutralizing antibodies.
• To assess the protective efficacy of peptide-induced immunity in a mouse model.

Main Methods:

• Synthesized a peptide (F164) from the carboxyl-terminal region of Mengo virus VP1 (residues 259-277).
• Immunized mice and guinea pigs with the F164 peptide.
• Assessed serum neutralizing antibody (SN) levels.
• Challenged immunized mice with a lethal dose of Mengo virus (100 LD50).

Main Results:

• The F164 peptide successfully induced SN antibodies in both mice and guinea pigs.
• Immunization with F164 resulted in high levels of protective neutralizing antibodies in mice.
• 87-100% of immunized mice were protected against a lethal Mengo virus challenge.
• The developed mouse model is effective for studying Mengo virus immune responses.

Conclusions:

• A peptide derived from Mengo virus VP1 (F164) is a potent inducer of neutralizing antibodies.
• This peptide confers significant protection against Mengo virus infection in mice.
• The F164 peptide represents a promising candidate for Mengo virus vaccine development.
• The mouse model is valuable for future research on Mengo virus immunogenicity.